Literature DB >> 3009181

Purification and characterization of a novel, oligomeric, plasminogen kringle 4 binding protein from human plasma: tetranectin.

I Clemmensen, L C Petersen, C Kluft.   

Abstract

Purification of alpha 2-plasmin inhibitor (alpha 2PI) from human plasma by affinity chromatography on plasminogen-Sepharose resulted in copurification of a contaminating protein with Mr 17,000 as judged by sodium dodecyl sulphate/polyacrylamide gel electrophoresis. This contaminating protein could not be removed from the purified alpha 2-PI preparation by several types of gel chromatography applied. The use of the kringle 1-3 part of plasminogen, K(1 + 2 + 3), bound to Sepharose for affinity chromatography, instead of plasminogen-Sepharose, resulted in an alpha 2PI preparation without this contaminant. The contaminating protein was found to interact specifically with the kringle 4 part of plasminogen (K4) and not with K(1 + 2 + 3) or miniplasminogen. The K4-binding protein was purified by ammonium sulphate precipitation, affinity chromatography on K4-Sepharose, ion-exchange chromatography and gel filtration on AcA 34. The relative molecular mass of the protein (Mr 68 000) was estimated by gel filtration. This suggests a tetrameric protein composed of four subunits (Mr 17,000), that are dissociated by 1% sodium dodecyl sulphate. Dissociation into subunits was also demonstrated by gel filtration in the presence of 6 M guanidine hydrochloride. A specific antibody was raised in rabbits against the purified protein and this antibody was shown not to react with any known fibrinolytic components. The pI of the K4-binding protein was found to be 5.8. The first three N-terminal amino acids were determined to be Glu-Pro-Pro. The concentration of the protein in plasma was estimated to be 0.20 +/- 0.03 microM (15 +/- 2 mg/l). The electrophoretic mobility of the K4-binding protein was shown by crossed immunoelectrophoresis to be influenced by the presence of Ca2+, EDTA and heparin. The protein was found to enhance plasminogen activation catalyzed by tissue-type plasminogen activator (t-PA) in the presence of poly(D-lysine). The protein appeared to be a novel plasma protein tentatively called 'tetranectin'.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3009181     DOI: 10.1111/j.1432-1033.1986.tb09586.x

Source DB:  PubMed          Journal:  Eur J Biochem        ISSN: 0014-2956


  42 in total

1.  Contractile function and sarcolemmal permeability after acute low-load resistance exercise with blood flow restriction.

Authors:  Mathias Wernbom; Gøran Paulsen; Tormod S Nilsen; Jonny Hisdal; Truls Raastad
Journal:  Eur J Appl Physiol       Date:  2011-09-27       Impact factor: 3.078

2.  Detection and characterization of natural and inducible lectins in human serum.

Authors:  Beulaja Manikandan; Manikandan Ramar
Journal:  Results Immunol       Date:  2012-06-07

3.  Zinc-dependent dimers observed in crystals of human endostatin.

Authors:  Y H Ding; K Javaherian; K M Lo; R Chopra; T Boehm; J Lanciotti; B A Harris; Y Li; R Shapiro; E Hohenester; R Timpl; J Folkman; D C Wiley
Journal:  Proc Natl Acad Sci U S A       Date:  1998-09-01       Impact factor: 11.205

4.  The cartilage-specific lectin C-type lectin domain family 3 member A (CLEC3A) enhances tissue plasminogen activator-mediated plasminogen activation.

Authors:  Daniela Lau; Dzemal Elezagic; Gabriele Hermes; Matthias Mörgelin; Alexander P Wohl; Manuel Koch; Ursula Hartmann; Stefan Höllriegl; Raimund Wagener; Mats Paulsson; Thomas Streichert; Andreas R Klatt
Journal:  J Biol Chem       Date:  2017-11-16       Impact factor: 5.157

5.  Mice with a targeted deletion of the tetranectin gene exhibit a spinal deformity.

Authors:  K Iba; M E Durkin; L Johnsen; E Hunziker; K Damgaard-Pedersen; H Zhang; E Engvall; R Albrechtsen; U M Wewer
Journal:  Mol Cell Biol       Date:  2001-11       Impact factor: 4.272

6.  Delayed fracture healing in tetranectin-deficient mice.

Authors:  Kousuke Iba; Yasuhisa Abe; Takako Chikenji; Kumiko Kanaya; Hironori Chiba; Koichi Sasaki; Takayuki Dohke; Takuro Wada; Toshihiko Yamashita
Journal:  J Bone Miner Metab       Date:  2013-04-16       Impact factor: 2.626

7.  Identification of tetranectin as a potential biomarker for metastatic oral cancer.

Authors:  Martha E Arellano-Garcia; Roger Li; Xiaojun Liu; Yongming Xie; Xiaofei Yan; Joseph A Loo; Shen Hu
Journal:  Int J Mol Sci       Date:  2010-09-02       Impact factor: 5.923

8.  Identification of a highly mobilizable subset of human neutrophil intracellular vesicles that contains tetranectin and latent alkaline phosphatase.

Authors:  N Borregaard; L Christensen; O W Bejerrum; H S Birgens; I Clemmensen
Journal:  J Clin Invest       Date:  1990-02       Impact factor: 14.808

9.  Immunohistochemical localization of a novel, human plasma protein, tetranectin, in human endocrine tissues.

Authors:  L Christensen; N Johansen; B A Jensen; I Clemmensen
Journal:  Histochemistry       Date:  1987

10.  Differences in tetranectin immunoreactivity between benign and malignant breast tissue.

Authors:  L Christensen; I Clemmensen
Journal:  Histochemistry       Date:  1991
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.